Celebrex Sales Data
| Rank 21 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Celebrex U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 21 | $580,332 | 5.23% | 950 | 1.71% |
| Q3 2013 | 21 ( 1) |
$551,508 | 3.46% | 934 | -9.50% |
| Q2 2013 | 22 | $533,077 | 2.85% | 1,032 | 2.28% |
| Q1 2013 | 22 | $518,329 | 2.47% | 1,009 | -4.90% |
| Q4 2012 | 22 | $505,850 | 2.61% | 1,061 | 2.41% |
| Q3 2012 | 22 (9) |
$492,984 | 12.77% | 1,036 | 3.70% |
| Q2 2012 | 31 (1) |
$437,140 | 1.43% | 999 | 2.25% |
| Q1 2012 | 32 | $430,993 | 1.08% | 977 | -5.42% |
| Q4 2011 | 32 ( 2) |
$426,391 | 1.12% | 1,033 | 1.47% |
| Q3 2011 | 30 (2) |
$421,670 | -4.82% | 1,018 | -4.32% |
| Q2 2011 | 28 (1) |
$443,024 | 1.25% | 1,064 | 2.01% |
| Q1 2011 | 29 | $437,533 | n/a | 1,043 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
